Omnicell
OMCL
240 hedge funds and large institutions have $1.25B invested in Omnicell in 2024 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 96 increasing their positions, 83 reducing their positions, and 52 closing their positions.
369% more call options, than puts
Call options by funds: $4.23M | Put options by funds: $901K
16% more repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 83
2.18% more ownership
Funds ownership: 98.7% → 100.87% (+2.2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less capital invested
Capital invested by funds: $1.34B → $1.25B (-$82.8M)
10% less funds holding
Funds holding: 266 → 240 (-26)
46% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 52
Top Buyers
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$26.3M |
| 2 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$14.7M |
| 3 |
Jane Street
New York
|
+$12.6M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$6.61M |
| 5 |
State Street
Boston,
Massachusetts
|
+$5.41M |
Top Sellers
OMCL Hedge Fund Activity: Q2 2024 in Review
240 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Omnicell (OMCL) for Q2 2024, worth a combined $1.25B — down 6.2% from $1.34B a quarter earlier.
Sellers outnumbered buyers: 52 funds closed out of OMCL and 28 opened new positions — a net loss of 24 holders — while 83 trimmed existing stakes and 96 added.
The largest buyer was Federated Hermes, adding an estimated $26.3M. The largest seller was Mirae Asset Global Investments, cutting an estimated $16M.
- 240 institutional investors held Omnicell (OMCL) as of Q2 2024, down from 266 in Q1 2024.
- Funds reported $1.25B of Omnicell stock for Q2 2024, down 6.2% quarter-over-quarter.
- 28 funds opened new Omnicell positions in Q2 2024 and 52 closed out, a net change of -24 holders.
- The largest Omnicell buyer in Q2 2024 was Federated Hermes, an estimated $26.3M added.
- The largest Omnicell seller in Q2 2024 was Mirae Asset Global Investments, an estimated $16M sold.
Based on aggregated 13F filings for Q2 2024.